Haemodynamic Feasibility Study of Sensors Within a Tilting Table Examination

This study´s aim is to explore physiological associations concerning pulse wave velocity, heart rate and blood pressure in order to make taking the blood pressure more comfortable.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Syncope Consciousness Disorders Nervous System Diseases Neurobehavioral Manifestations Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms Unconsciousness

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Univeristy Hospital Aachen

Aachen, North Rhine Westfalia, 52074, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients with syncope and planned tilting table investigation
male and female patients aged at least 18 years
persons being able to understand and to follow the study stuff´s instructions

Exclusion criteria

pregnancy or breast feeding
patients not being able to consent
cardiac pacemaker / defibrillator
illness of skin

Treatment and study plan

measurement of blood pressure

Device

measurement of pulse wave velocity

Primary outcomes

data about possible correlation

Time frame: 45 minutes

Correlation between pulse wave velocity, pulse rate and blood pressure

Sponsors and collaborators

Lead sponsor

RWTH Aachen University

Other

Registry information

Important dates

Study start: 2012
Primary completion: 2013
Study completion: 2013
First posted: Apr 15, 2013
Registry last updated: Nov 27, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed